Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
138
days
From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars
Authors
Anita Krishnan; Somesh BP; Gaurav Mehta; Shilpa Ramaswamy; Soumen Chakraborty; Shyamapada MandalShow moreShow less
Affiliations
1. Biocon BiologicsShow moreShow less
91
days
From analytical similarity to clinical confidence: how regulatory evolution ensures comparable immunogenicity in streamlined biosimilar development
Authors
Sandra Ribes; Marc Rosenbaum; Laura Hartmann; Lisa Allmannsberger; Johann PoetzlShow moreShow less
Affiliations
1. Hexal AG (a Sandoz company)Show moreShow less
83
days
A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma
Authors
Fatma H. Ghazy; Ramzia I. El-Bagary; Samar H. Fahim; Sally T. MahmoudShow moreShow less
Affiliations
1. Cairo University; 2. School of Pharmacy, New GizaShow moreShow less
176
days
Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application
Authors
Abdul-Azeez A. Lanihun; Oluwatobi T. Arisa; Olivia Poczatek; Yi Zeng; Nam Hoon Kwon; Sunghoon Kim; Sandra Cooper; Jason M. Elinoff; William D. FiggShow moreShow less
Affiliations
1. Clinical Pharmacology Laboratory, Clinical Center, National Institutes of Health, Bethesda, MD, USA; 2. Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, Washington, DC, USA; 3. Research Institute, Zymedi Co., Ltd., Incheon, South Korea; 4. Department of Integrative Biotechnology, Interdisciplinary Graduate Program, Yonsei University, Incheon, South Korea; 5. Critical Care Medicine and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; 6. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA; 7. Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USAShow moreShow less
27
days
Highlights from the 17th Japan Bioanalysis Forum Symposium
Authors
Katsutomo Hata; Naohito Yamada; Hiroyuki Shimizu; Tomoko Arakawa; Hitoshi Uchiyama; Miyuki Ugajin; Takeshi Okuzono; Eiichi Shimada; Masanori Nagata; Masayo Hashimoto; Hisanori Hara; Takashi Miyayama; Tamiki Mori; Ken-Ichi YamamotoShow moreShow less
Affiliations
1. Shionogi & Co., Ltd; 2. Tanabe Pharma Corporation; 3. Pfizer R&D Japan G.K; 4. Towa Pharmaceutical Co., Ltd; 5. Takeda Pharmaceutical Co., Ltd; 6. Sekisui Medical Co., Ltd; 7. Ono Pharmaceutical Co., Ltd; 8. Astellas Pharma Inc; 9. Otsuka Pharmaceutical Co., Ltd; 10. B2S Life Sciences LLC; 11. Chugai Pharmaceutical Co., Ltd; 12. Mediford Corporation; 13. Shin Nippon Biomedical Laboratories, LtdShow moreShow less
65
days
Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies
Authors
Pietro Piu; Stefano Auddino; Gioele Bernardoni; Emanuele Montomoli; Alessandro ManentiShow moreShow less
Affiliations
1. VisMederi S.r.l; 2. University of SienaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
